Korro Bio, Inc.
KRRO
$20.15
$0.0750.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.69% | -0.31% | -22.39% | 31.04% | 30.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.81% | 28.51% | -5.88% | 21.64% | 31.06% |
| Operating Income | -12.75% | -16.63% | 14.33% | -21.64% | -31.06% |
| Income Before Tax | -18.23% | -19.69% | 17.03% | -13.61% | -23.69% |
| Income Tax Expenses | -96.67% | -- | -- | -- | 11.11% |
| Earnings from Continuing Operations | -18.07% | -19.58% | 16.62% | -13.56% | -23.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.07% | -19.58% | 16.62% | -13.56% | -23.67% |
| EBIT | -12.75% | -16.63% | 14.33% | -21.64% | -31.06% |
| EBITDA | -10.99% | -14.80% | 15.91% | -23.03% | -33.81% |
| EPS Basic | -12.99% | -2.20% | 52.96% | 96.53% | 96.20% |
| Normalized Basic EPS | -13.14% | -2.29% | 53.19% | 96.53% | 96.19% |
| EPS Diluted | -12.99% | -2.20% | 52.96% | 96.53% | 96.20% |
| Normalized Diluted EPS | -13.14% | -2.29% | 53.19% | 96.53% | 96.19% |
| Average Basic Shares Outstanding | 4.50% | 17.02% | 77.24% | 3,173.47% | 3,150.09% |
| Average Diluted Shares Outstanding | 4.50% | 17.02% | 77.24% | 3,173.47% | 3,150.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |